secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2026-05-11T20:11:38+00:00
Accession:  0001459839-26-000054
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE Q1 revenue $52.6M (+11%), net loss improves 33.8%; raises FY26 guidance
-------------------------------------------------------------------------------

- Worldwide revenue $52.6M (+11.2% YoY); US revenue $49.3M (+10.0%), international $3.3M (+33.9%).
- Net loss $4.3M (-33.8% YoY, -$0.10 diluted EPS); adjusted EBITDA $2.5M (vs $0.5M, >440% improvement).
- Gross margin stable at 79.8%; operating loss improved 31.9% to $5.1M.
- Raised FY2026 revenue guidance to $230-233M (prior $228.5-232.5M); gross margin ~79% (prior ~78%).
- Operational: over 1,650 active US physicians (+17%); CMS proposes new MS-DRG for complex spinal fusion with iFuse Bedrock Granite.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983926000054/0001459839-26-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983926000054/sibn-20260511.htm
  HTML page:      https://secwatch.observer/filing/0001459839-26-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer